← Back to Clinical Trials
Recruiting NCT07035236

NCT07035236 Evaluation of Tenting the Schneiderian Membrane of the Maxillary Sinus Using Titanium Mesh.

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07035236
Status Recruiting
Phase —
Sponsor Suez Canal University
Condition Maxillary Sinus Floor Augmentation
Study Type INTERVENTIONAL
Enrollment 20 participants
Start Date 2025-07-15
Primary Completion 2026-10

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 60 Years
Study Type INTERVENTIONAL
Interventions
maxillary sinus liftingMaxillary sinus lifting

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 20 participants in total. It began in 2025-07-15 with a primary completion date of 2026-10.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Twenty posterior maxillary edentulous sites requiring open sinus augmentation for staged dental implant placement will be studied. Group I (study group) the maxillary sinus membrane will be elevated using titanium mesh fixed by bone screws. Group II (control group) will have stainless steel screws/pins placed bucco-palatally to maintain the elevated membrane and stabilize the formed blood clot. Platelet rich fibrin (PRF) will be placed at the site of elevated membrane in both groups.

Eligibility Criteria

Inclusion Criteria: * Adult male/female patients with age interval 18:60 years old. * Patients with one or more teeth requiring implant supported dental restoration in atrophic maxilla. * Alveolar bone height less than 5 mm at the defective site. * Good oral hygiene. * Patient's consensual agreement to be enrolled in the study. Exclusion Criteria: * Medically compromised patients with conditions contraindicating surgery (eg. uncontrolled diabetics, bisphosphonate intake, radio or chemotherapy). * Patients with active infection at or related to the site of surgery (eg. acute sinusitis). * Heavy smokers. * Patients not indicated for an implant supported restoration at the time of enrollement (eg. active/untreated periodontal disease). (Patients developing any medical condition that interferes with the outcomes after enrolment in the study will be excluded).

Contact & Investigator

Central Contact

Hedra Sherif Michael

✉ Hedra_sherif@dent.suez.edu.eg

📞 +201226182970

Frequently Asked Questions

Who can join the NCT07035236 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 60 Years, studying Maxillary Sinus Floor Augmentation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07035236 currently recruiting?

Yes, NCT07035236 is actively recruiting participants. Contact the research team at Hedra_sherif@dent.suez.edu.eg for enrollment information.

Where is the NCT07035236 trial being conducted?

This trial is being conducted at Ismailia, Egypt.

Who is sponsoring the NCT07035236 clinical trial?

NCT07035236 is sponsored by Suez Canal University. The trial plans to enroll 20 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology